Status:
RECRUITING
Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
De Quervain Disease
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
De Quervain disease is characterized by an adductor pollicis longus and extensor pollicis brevis tendons inflammation as thys pass beneath the extensor retinaculum at the radial styloid. This patholog...
Eligibility Criteria
Inclusion
- Male or female patient aged 18 to 75,
- Patient with unilateral De Quervain's tenosynovitis,
- Patient cared in the Hand Surgery Department, SOS Mains Emergency Department or Rheumatology Department of Strasbourg University Hospitals,
- Patient informed of the results of the prior medical examination,
- Informed consent signed by the patient,
- Patient affiliated to a health insurance social protection scheme or beneficiary,
- For a woman of childbearing potential, negative urine pregnancy test at the inclusion visit and maintenance of effective contraception throughout the study.
Exclusion
- Pregnant or breastfeeding patient,
- Patient allergic to a component of the gel with essential oils, Dicloflenac®, NSAIDs, or one of the excipients
- Patient treated with oral non-steroidal anti-inflammatory drugs
- Patient with ongoing treatment with another ointment at the treatment application site (radial edge of the wrist)
- Patient with damaged skin, whatever the lesion: oozing dermatosis, eczema, infected lesion, burn or wound,
- Patient with atopic skin disease,
- Patient with epilepsy or with a history of epilepsy,
- Patient with a history of homolateral De Quervain's tenosynovitis, or having already had corticosteroid infiltrations in the 6 months before his inclusion on the ipsilateral side of the pathology,
- Patient with associated tendinopathies in the elbow or forearm region,
- Impossibility of giving the patient information (patient in an emergency situation, patient with difficulties of understandin, agitation of the patient),
- Patient under legal protection, under guardianship or curatorship.
Key Trial Info
Start Date :
June 4 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06012097
Start Date
June 4 2024
End Date
April 1 2026
Last Update
August 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service SOS Main
Strasbourg, France, 67000